| Literature DB >> 26929613 |
Hyung-Jun Kim1, Jinwoo Lee1, Young Sik Park1, Chang-Hoon Lee1, Sang-Min Lee1, Jae-Joon Yim1, Chul-Gyu Yoo1, Young Whan Kim1, Sung Koo Han1, Sun Mi Choi1.
Abstract
PURPOSE: Chronic obstructive pulmonary disease (COPD) is associated with increased postoperative complications. Recently, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classified COPD patients into four groups based on spirometry results and the severity of symptoms. The objective of this study was to evaluate the impact of GOLD groups on postoperative complications. PATIENTS AND METHODS: We reviewed the medical records of COPD patients who underwent preoperative spirometry between April and August 2013 at a tertiary hospital in Korea. We divided the patients into GOLD groups according to the results of spirometry and self-administered questionnaires that assessed the symptom severity and exacerbation history. GOLD groups, demographic characteristics, and operative conditions were analyzed.Entities:
Keywords: chronic obstructive pulmonary disease; dyspnea; postoperative complications; risk assessment; spirometry
Mesh:
Year: 2016 PMID: 26929613 PMCID: PMC4755694 DOI: 10.2147/COPD.S95046
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Baseline characteristics of study patients
| Variables | Patients without postoperative complications, n=335 | Patients with postoperative complications, n=70 | |
|---|---|---|---|
| Age | 70 (46–91) | 71 (44–88) | 0.841 |
| Male sex | 281 (83.9) | 66 (94.3) | 0.024 |
| BMI (kg/m2) | 23.51±2.90 | 22.44±3.18 | 0.006 |
| Smoking history | 239 (71.3) | 64 (91.4) | <0.001 |
| Underlying disease | |||
| Hypertension | 172 (51.3) | 34 (48.6) | 0.673 |
| Diabetes mellitus | 64 (19.1) | 14 (20.0) | 0.863 |
| Tuberculosis | 37 (11.0) | 4 (5.7) | 0.179 |
| Liver disease | 33 (9.9) | 10 (14.3) | 0.273 |
| Heart disease | 46 (13.7) | 9 (12.9) | 0.846 |
| Renal disease | 16 (4.8) | 4 (5.7) | 0.761 |
| Neurologic disease | 37 (11.0) | 10 (14.3) | 0.441 |
| Malignancy | 158 (47.2) | 47 (67.1) | 0.002 |
| ASA physical status | 0.998 | ||
| 1 | 38 (11.3) | 8 (11.4) | |
| 2 | 269 (80.3) | 56 (80.0) | |
| 3 | 28 (8.4) | 6 (8.6) | |
| PFT values | |||
| FVC, % predicted | 103.64±15.86 | 102.10±15.63 | 0.461 |
| FEV1, % predicted | 94 (84–106) | 90 (94.5–102.25) | 0.044 |
| FEV1/FVC, % | 64 (59–67) | 63 (53.5–68) | 0.226 |
Notes: Data are presented as numbers (%) unless otherwise indicated.
Median (range),
mean ± SD,
median (interquartile range).
Abbreviations: BMI, body mass index; ASA, American Society of Anesthesiologists; PFT, pulmonary function test; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
Types of postoperative complications
| Category | Postoperative complication | n (%) |
|---|---|---|
| Pulmonary | 20 (4.9) | |
| Pneumonia | 11 (2.7) | |
| Pleural effusion | 9 (2.2) | |
| Atelectasis | 4 (1.0) | |
| Infection | 22 (5.4) | |
| Organ specific infection | 19 (4.7) | |
| Bloodstream infection | 3 (0.7) | |
| Septic shock | 1 (0.2) | |
| Renal | 6 (1.5) | |
| Acute kidney injury | 6 (1.5) | |
| Dialysis | 2 (0.5) | |
| Cardiac | 4 (1.0) | |
| Arrhythmia | 4 (1.0) | |
| Wound | 27 (6.7) | |
| Major | 17 (4.2) | |
| Minor | 10 (2.5) | |
| Others | 13 (3.2) | |
| Acute urinary retention | 7 (1.7) | |
| Delirium | 6 (1.5) |
Note: More than one postoperative complication could occur in each patient.
Surgical information of patients with and without complications
| Variables | Patients without postoperative complications, n=335 | Patients with postoperative complications, n=70 | |
|---|---|---|---|
| Surgery site | |||
| Brain | 13 (3.9) | 0 (−) | 0.137 |
| Head and neck | 44 (13.1) | 3 (4.3) | 0.036 |
| Thorax | 8 (2.4) | 6 (8.6) | 0.021 |
| Upper abdomen | 54 (16.1) | 29 (41.4) | <0.001 |
| Lower abdomen | 36 (10.7) | 9 (12.9) | 0.675 |
| Genitourinary | 94 (28.1) | 11 (15.7) | 0.032 |
| Orthopedic | 45 (13.4) | 7 (10.0) | 0.435 |
| General anesthesia | 268 (80.0) | 69 (98.6) | <0.001 |
| Emergency operation | 7 (2.1) | 0 (−) | 0.610 |
| Anesthesia time (hours) | 1.92 (1.17–3.33) | 4.62 (3.17–5.83) | <0.001 |
| EBL (L) | 0.02 (0.00–0.15) | 0.40 (0.15–0.96) | <0.001 |
Notes: Data are presented as numbers (%) unless otherwise indicated.
Median (interquartile range).
Abbreviation: EBL, estimated blood loss.
Distribution of postoperative complications based on the COPD group
| Comparison | Patients without complications, n=335 | Patients with complications, n=70 | |
|---|---|---|---|
| GOLD grade | 0.020 | ||
| 1 | 272 (81.2) | 48 (68.6) | |
| 2 | 54 (16.1) | 17 (24.3) | |
| 3 | 9 (2.7) | 4 (5.7) | |
| 4 | 0 (−) | 1 (1.4) | |
| GOLD group | 0.056 | ||
| A | 210 (62.7) | 41 (58.6) | |
| B | 110 (32.8) | 20 (28.6) | |
| C | 7 (2.1) | 4 (5.7) | |
| D | 8 (2.4) | 5 (7.1) | |
| Risk assessment | 0.047 | ||
| Low risk (A or B) | 319 (95.2) | 62 (88.6) | |
| High risk (C or D) | 16 (4.8) | 8 (11.4) | |
| Level of symptoms | >0.999 | ||
| Less symptoms (A or C) | 217 (64.8) | 45 (64.3) | |
| More symptoms (B or D) | 118 (35.2) | 25 (35.7) |
Notes: Data are presented as numbers (%).
GOLD grade is defined as: 1, FEV1 ≥80% predicted; 2, 50% ≤ FEV1 <80% predicted; 3, 30% ≤ FEV1 <50% predicted; 4, FEV1 <30% predicted.
Abbreviations: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
Multivariable analysis for factors related to postoperative complications
| Variables | OR | 95% CI | |
|---|---|---|---|
| High-risk group | 4.023 | 1.312–12.335 | 0.015 |
| Male sex | 0.620 | 0.134–2.871 | 0.541 |
| BMI (kg/m2) | 0.962 | 0.864–1.072 | 0.484 |
| Smoking history | 6.079 | 1.704–21.687 | 0.005 |
| Underlying malignancy | 1.112 | 0.552–2.243 | 0.766 |
| Thoracic surgery | 2.069 | 0.555–7.714 | 0.279 |
| Upper abdominal surgery | 1.883 | 0.927–3.827 | 0.080 |
| Estimated blood loss (L) | 1.788 | 1.076–2.972 | 0.025 |
| General anesthesia | 4.547 | 0.566–36.541 | 0.154 |
| Anesthesia time (hours) | 1.445 | 1.205–1.732 | <0.001 |
Note:
GOLD groups C or D.
Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index; GOLD, Global Initiative for Chronic Obstructive Lung Disease.
Multivariate analysis of postoperative pulmonary complications, infection, and wound complications
| Variables | OR | 95% CI | |
|---|---|---|---|
| Postoperative pulmonary complication | |||
| High-risk group | 1.103 | 0.187–6.510 | 0.914 |
| Upper abdominal surgery | 3.155 | 1.208–8.238 | 0.019 |
| EBL (L) | 1.591 | 1.051–2.409 | 0.028 |
| Postoperative infection | |||
| High-risk group | 3.755 | 1.053–13.387 | 0.041 |
| BMI (kg/m2) | 0.847 | 0.727–0.987 | 0.034 |
| EBL (L) | 1.909 | 1.285–2.836 | 0.001 |
| Postoperative wound complication | |||
| High-risk group | 5.883 | 1.642–21.082 | 0.007 |
| EBL (L) | 1.593 | 1.014–2.503 | 0.043 |
| Smoking history | 11.532 | 1.393–95.472 | 0.023 |
| Upper abdominal surgery | 3.846 | 1.607–9.209 | 0.002 |
Notes:
Adjusted for underlying heart disease, underlying malignancy, upper abdominal surgery, EBL, and general anesthesia;
GOLD groups C and D;
adjusted for BMI, underlying malignancy, upper abdominal surgery, EBL, and general anesthesia;
adjusted for BMI, underlying malignancy, smoking history, upper abdominal surgery, EBL, and general anesthesia.
Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index; EBL, estimated blood loss.
Relationship between dyspnea and postoperative complications
| Symptom assessment | Patients without postoperative complications, n=335 | Patients with postoperative complications, n=70 | |
|---|---|---|---|
| mMRC | 0.724 | ||
| <2 | 278 (83.0) | 60 (85.7) | |
| ≥2 | 57 (17.0) | 10 (14.3) | |
| CAT | 0.885 | ||
| <10 | 238 (71.0) | 49 (70.0) | |
| ≥10 | 97 (29.0) | 21 (30.0) |
Note: Data are presented as numbers (%).
Abbreviations: mMRC, modified medical research scale; CAT, COPD assessment test.